newsfilter
← Latest News
Business Wire·

TriSalus Life Sciences Announces Pricing of $40.0 Million Public Offering

TriSalus Life Sciences, Inc. (NASDAQ:TLSI) ("TriSalus" or the "Company"), an oncology focused medical technology company advancing novel drug delivery technologies alongside standard-of-care therapies to improve